Nikhil Phadke
QuickFISH Products | Staphylococcus QuickFISH,Enterococcus QuickFISH,Gram-Negative QuickFISH,Candida QuickFISH。 |
PNA FISH Products | S. aureus/CNS PNA FISH,E. faecalis/OE PNA FISH,Gram-Negative PNA FISH,Candida PNA FISH,XpressFISH,mecA XpressFISHTM。 |
Accessories | Clinical Benefits Studies |
融资轮次 | 融资日期 | 投资方 | 融资额度 |
---|---|---|---|
Venture | 2005-01 | 未披露 | $5M |
Series A | 2007-09 | Versant Ventures,Highland Capital Partners,CHL Medical Partners | $23.6M |
Debt Financing | 2010-01 | 未披露 | $4.05M |
Debt Financing | 2010-05 | 未披露 | $4.02M |
Series B | 2010-09 | 未披露 | $17M |
Debt Financing | 2012-02 | 未披露 | $3.53M |
Series C | 2012-03 | Harris & Harris Group | $17M |
Debt Financing | 2014-04 | 未披露 | $4M |
Debt Financing | 2014-07 | 未披露 | $1.08M |
Debt Financing | 2015-02 | 未披露 | $1.24M |
Venture | 2015-07 | Merck Global Health Innovation Fund | $6M |
Post Ipo Equity | 2016-06 | Merck Global Health Innovation Fund | $10.4M |
Post Ipo Equity | 2016-11 | Merck Global Health Innovation Fund | $6M |